precirol has been researched along with repaglinide in 1 studies
| Studies (precirol) | Trials (precirol) | Recent Studies (post-2010) (precirol) | Studies (repaglinide) | Trials (repaglinide) | Recent Studies (post-2010) (repaglinide) |
|---|---|---|---|---|---|
| 81 | 0 | 52 | 610 | 152 | 244 |
| Protein | Taxonomy | precirol (IC50) | repaglinide (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Homo sapiens (human) | 9.2 | |
| 5-hydroxytryptamine receptor 7 | Cavia porcellus (domestic guinea pig) | 9.2 | |
| ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 0.106 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Date, AA; Jagtap, A; Nagarsenker, MS; Vador, N | 1 |
1 other study(ies) available for precirol and repaglinide
| Article | Year |
|---|---|
Lipid nanocarriers (GeluPearl) containing amphiphilic lipid Gelucire 50/13 as a novel stabilizer: fabrication, characterization and evaluation for oral drug delivery.
Topics: Administration, Oral; Animals; Blood Glucose; Calorimetry, Differential Scanning; Carbamates; Diabetes Mellitus, Experimental; Diglycerides; Drug Carriers; Drug Delivery Systems; Drug Stability; Fats; Feasibility Studies; Glucose Tolerance Test; Lipids; Nanoparticles; Nanotechnology; Oils; Particle Size; Piperidines; Rats; Surface-Active Agents | 2011 |